🔴 Omada Health is trading 13.46% down in pre-market despite raising 2026 revenue and adjusted EBITDA guidance

Omada Health is trading at $16.40, down 13.46% in pre-market on November 6; available sources do not establish why shares are falling. - The price compares with the November 5 close of $18.95. - Third-quarter revenue was $91 million, up 34% year over year, and net income was $7 million. - Omada Health raised its 2026 revenue and adjusted EBITDA guidance.